Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results ...

Reports Q4 revenue $20.44M, consensus $20.19M. “2024 was a tremendous momentum-building year for Beta Bionics (BBNX). We ended the year with ...

XERS Xeris Biopharma Holdings, Inc.

Cibc World Markets Corp acquired a new stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC.

Connor Clark & Lunn Investment Management Ltd. raised its stake in shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – ...

Gvoke VialDx is a concentrated liquid glucagon product. For diagnostic procedures, it works as a gastrointestinal motility inhibitor. The product is supplied as a single-dose vial containing 1mg of ...

Aptose Biosciences Inc. ("Aptose" or the "Company") , a clinical-stage precision oncology company developing a tuspetinib (TUS)-based triple drug frontline therapy to treat patients with newly ...

Overview. The National Cancer Center (President: Hitoshi Nakagama, hereinafter "NCC") Hospital East (Director: Toshihiko Doi), The Nati ...

The SPDR S&P Biotech (MX:XBI) ETF (XBI +1.1%) is up 1% as investors ramp up buying ahead of the abstract drop for the American ...

WASHINGTON, March 24 (Reuters) - U.S. President Donald Trump said on Monday he will in the very near future announce tariffs on automobiles, aluminum and pharmaceuticals. Speaking to reporters at ...

Mar. 18, 2025 — A research team has found that lecanemab was probably less effective in females than males in its Phase 3 trial. However, there was insufficient evidence to say the drug was ...